DISCOUNT ZERTIFIKAT - MEDTRONIC Stock

Certificat

DE000PN6ANU3

Delayed Deutsche Boerse AG 01:20:14 2024-06-13 pm EDT
73.19 EUR +0.04% Intraday chart for DISCOUNT ZERTIFIKAT - MEDTRONIC
Current month+2.05%
1 month-0.08%
Date Price Change
24-06-13 73.19 +0.04%
24-06-12 73.16 -0.57%
24-06-11 73.58 -0.53%
24-06-10 73.97 -0.36%
24-06-07 74.24 +2.03%

Delayed Quote Deutsche Boerse AG

Last update June 13, 2024 at 01:20 pm EDT

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN6ANU
ISINDE000PN6ANU3
Date issued 2023-07-25
Maturity 2024-12-20 (190 Days)
Parity 1 : 1
Emission price 68.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 75.31
Lowest since issue 60.61
Spread 0.15
Spread %0.20%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
82.23 USD
Average target price
94.07 USD
Spread / Average Target
+14.40%
Consensus